Milestone Pharmaceuticals (MIST) Proxy Filing summary

Executive summary

• The annual meeting will be held virtually on August 28, 2024, with shareholders voting on director elections and auditor appointment, and receiving a report on company progress.

• Shareholders can vote online, by phone, mail, or during the virtual meeting, with detailed instructions provided for both record and beneficial owners.

• Proxy materials, including the annual report, are available online, and shareholders may request printed copies.

Voting matters and shareholder proposals

• Shareholders will vote on electing seven directors to serve until the 2025 annual meeting and on appointing PricewaterhouseCoopers LLP as auditor.

• The board recommends voting FOR all director nominees and the auditor appointment.

• Shareholder proposals and director nominations for the 2025 meeting must be submitted by specified deadlines and in accordance with company bylaws.

Board of directors and corporate governance

• The board consists of seven members, six of whom are independent; the chair is also independent.

• Board committees include Audit, Compensation, and Nominating and Corporate Governance, all composed of independent directors.

• The board emphasizes diversity, regular self-assessment, and ongoing director education.

• A cooperation agreement with Alta Fundamental Advisors LLC led to the appointment of two new directors in July 2024.